Khan M, Bui H X, del Rosario A, Abdulla M, Ballouk F, Sim Y J, Ross J S
Department of Pathology and Laboratory Medicine, Albany Medical College, New York.
Mod Pathol. 1994 Feb;7(2):169-74.
Progression to cancer in Barrett's esophageal columnar metaplasia is classically heralded by the presence of epithelial dysplasia. Differentiation of reactive epithelial atypia and mild dysplasia from severe dysplasia, however, may often be difficult especially with limited biopsy material. We performed DNA content analysis of 11 cases of Barrett's esophagus showing variable reactive atypia, 24 cases of Barrett's with low- and high-grade dysplasia, and 30 cases of Barrett's with invasive adenocarcinoma (BCA) using Feulgen-stained paraffin sections and the CAS 200 image analyzer. The mean DNA index of the uniformly diploid BE was 1.06. The 1.26 mean DNA index for the low-grade Barrett's esophagus with dysplasia, 1.62 for high grade, and 1.88 DI for BCA were significantly greater than for variable reactive atypia (P < 0.004) but not different from each other. Six BCA cases (20%) were diploid; 24 cases (80%) were aneuploid. Mean survival of diploid BCA at 20.4 mo was nearly double the survival of 10.6 mo for aneuploid BCA. However, this difference was not statistically significant (P < 0.21) and survival at 3 yr was identical for all BCA cases. Tumor grade, stage, and lymph node status did not significantly correlate with ploidy pattern. Thus, although DNA analysis does not seem to predict ultimate outcome in BCA, aneuploidy and high DNA index are associated with Barrett's esophagus with dysplasia and BCA and may be of significant value in the differentiation from variable reactive atypia in small biopsies.
巴雷特食管柱状化生进展为癌症的典型表现是上皮发育异常。然而,鉴别反应性上皮异型增生和轻度发育异常与重度发育异常往往很困难,尤其是活检材料有限时。我们使用福尔根染色石蜡切片和CAS 200图像分析仪,对11例显示不同反应性异型增生的巴雷特食管、24例低级别和高级别发育异常的巴雷特食管以及30例浸润性腺癌(BCA)的巴雷特食管进行了DNA含量分析。均匀二倍体BE的平均DNA指数为1.06。发育异常的低级别巴雷特食管平均DNA指数为1.26,高级别为1.62,BCA为1.88,均显著高于不同反应性异型增生(P < 0.004),但彼此之间无差异。6例BCA(20%)为二倍体;24例(80%)为非整倍体。二倍体BCA的平均生存期为20.4个月,几乎是非整倍体BCA 10.6个月生存期的两倍。然而,这种差异无统计学意义(P < 0.21),所有BCA病例3年时的生存率相同。肿瘤分级、分期和淋巴结状态与倍体模式无显著相关性。因此,尽管DNA分析似乎无法预测BCA的最终结局,但非整倍体和高DNA指数与发育异常的巴雷特食管和BCA相关联,在小活检中与不同反应性异型增生的鉴别中可能具有重要价值。